BioCentury
ARTICLE | Financial News

Emulate raises $36M series C to improve Organ-Chips offering

June 19, 2018 11:00 AM UTC

Emulate Inc. (Boston, Mass.) raised $36 million in a series C round led by Founders Fund. Fellow new investors ALS Investment Fund, SciFi VC and Glass Wall Syndicate also participated, as did undisclosed existing investors.

Emulate plans to use the funds to expand the functionality of its Human Emulation System so that it can be applied by the pharmaceutical industry across the entire drug discovery and development process. It will add advanced biological capabilities to its Organ-Chips, human-relevant disease models of thrombosis and immune system modulation and new software applications that enable data analysis...